Translation of orofacial sciences (translational research, education, advocacy)
Following graduation as a dentist from the University of Otago in New Zealand, Mike did a PhD in Biochemistry (Otago), spent a year in private dental practice, then undertook postdoctoral research fellowships investigating calcium signalling with Claude Klee (National Cancer Institute, NIH, USA) and protein phosphorylation with Sir Philip Cohen (University of Dundee, Scotland). On return to Otago in 1990, he established his independent biomedical research career focusing on biochemical peculiarities of the cells that form dental enamel.
In 2003, Mike shifted camp to The University of Melbourne. Based in the Faculty of Medicine, Dentistry and Health Sciences, his overall mission was to promote translational research and education in the oral and facial sciences with a focus on prevalent tooth and bone problems.
New Translational Initiatives
Since 2003, Mike has spear-headed development of the Melbourne Research Unit for Facial Disorders
into a pioneering translational research initiative with active fronts in oral health and biomedical technology. Two network-groups and a commercial start-up have ensued alongside breakthrough research.
First, he instigated a cross-sector technology network known today as Proteomics & Metabolomics Victoria
. This initiative has strengthened the sector through several key improvements (unity, technology access, communication, education, strategy & advocacy).
Second, he instigated The D3 Group for Developmental Dental Defects
. This Australasian network is now being internationalised and brings together a broad medico-dental community (researchers, clinicians, public health, industry & affected families) with the aim to improve understanding and care of people with "chalky teeth" (D3s). In 2013 Mike launched a comprehensive on
Editorial Board, Current Proteomics.
Board member 2007 -